發(fā)布時(shí)間：2018-06-19 13:26

  本文選題：單腔球囊 + 雙腔球囊　； 參考：《蘇州大學(xué)》2016年碩士論文

【摘要】：目的:本論文通過比較160ml單、雙球囊引產(chǎn)用于足月妊娠促宮頸成熟的臨床效果,探討相同容量單、雙腔球囊引產(chǎn)在產(chǎn)科實(shí)際應(yīng)用中的優(yōu)缺點(diǎn),為提高臨床足月妊娠促宮頸成熟效果提供證據(jù)及經(jīng)驗(yàn)。方法:對(duì)收集的符合引產(chǎn)指征、宮頸Bishop評(píng)分6分、單胎頭位孕足月的160例初產(chǎn)婦進(jìn)行引產(chǎn)效果分析。160例孕婦分成兩組:研究組:80例采用宮頸擴(kuò)張單腔球囊引產(chǎn).對(duì)照組:80例采用Cook宮頸擴(kuò)張雙腔球囊引產(chǎn)。觀察兩組受試者妊娠合并癥、宮頸Bishop評(píng)分、圍生兒結(jié)局、引產(chǎn)過程、引產(chǎn)結(jié)局以及不良事件發(fā)生率。本研究征得受試對(duì)象知情同意,并與之簽署臨床研究知情同意書。結(jié)果:1.研究組與對(duì)照組兩組患者在年齡(歲)、孕次(次)、產(chǎn)次(次)、分娩孕齡(周)以及孕婦體質(zhì)量指數(shù)(kg/m2)等基本資料之間差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義。2.研究組與對(duì)照組兩組患者在妊娠期糖尿病例數(shù)以及妊娠期高血壓疾病例數(shù)之間差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義;研究組與對(duì)照組兩組患者在羊水偏少例數(shù)之間差異顯著(P0.05),有統(tǒng)計(jì)學(xué)意義。3.治療前研究組與對(duì)照組促宮頸成熟比較無顯著差異(P0.05),無統(tǒng)計(jì)學(xué)意義。治療后研究組與對(duì)照組促宮頸成熟比較差異顯著(P0.05),有統(tǒng)計(jì)學(xué)意義;研究組球囊作用時(shí)間明顯短于對(duì)照組(P0.05),有統(tǒng)計(jì)學(xué)意義;研究組促宮頸成熟有效率顯著高于對(duì)照組(P0.05),有統(tǒng)計(jì)學(xué)意義。研究組球囊脫落率明顯高于對(duì)照組(P0.05),有統(tǒng)計(jì)學(xué)意義。4.研究組與對(duì)照組兩組患者在新生兒出生體質(zhì)量(g)、身長(zhǎng)(cm)、新生兒窒息例數(shù)[n(%)]以及胎兒窘迫例數(shù)[n(%)]這些圍生兒結(jié)局情況之間差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義。5.研究組與對(duì)照組兩組患者在感染等并發(fā)癥之間差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義;在產(chǎn)后出血、臍帶脫垂并發(fā)癥方面差異顯著(P0.05),有統(tǒng)計(jì)學(xué)意義。6.研究組與對(duì)照組兩組患者在引產(chǎn)成功率、剖宮產(chǎn)率之間差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義;研究組與對(duì)照組兩組在臨產(chǎn)時(shí)間、第一產(chǎn)程、潛伏期產(chǎn)程方面差異顯著(P0.05),有統(tǒng)計(jì)學(xué)意義。在活躍期以及第二產(chǎn)程差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義。7.研究組與對(duì)照組改行剖宮產(chǎn)總例數(shù)差異不顯著(P0.05),無統(tǒng)計(jì)學(xué)意義。研究組中由于社會(huì)因素、臍帶脫垂改行剖宮產(chǎn)的例數(shù)顯著高于對(duì)照組(P0.05),有統(tǒng)計(jì)學(xué)意義。研究組中由于產(chǎn)程異常改行剖宮產(chǎn)的例數(shù)顯著低于對(duì)照組(P0.05),有統(tǒng)計(jì)學(xué)意義。研究組中由于胎兒窘迫改行剖宮產(chǎn)的例數(shù)與對(duì)照組無顯著差異(P0.05),無統(tǒng)計(jì)學(xué)意義。結(jié)論:相同容量的單雙腔球囊在足月妊娠引產(chǎn)中各有利弊,臨床工作應(yīng)具體情況具體分析,以提高產(chǎn)科質(zhì)量,減少不良事件的發(fā)生。
[Abstract]:Objective: to compare the clinical effect of 160ml single and double balloon induced labor in term pregnancy and to explore the advantages and disadvantages of the same volume single and double chamber balloon induction in obstetrics. To improve the clinical term pregnancy to promote cervical maturation effect to provide evidence and experience. Methods: according to the indication of induced labor, the cervical Bishop score was 6 points and 160 primiparas with single fetal head position were analyzed. 160 pregnant women were divided into two groups: study group: 80 cases were induced labor by cervical dilatation single chamber balloon. 80 cases of control group were treated with Cook's dilated double chamber balloon to induce labor. The complications of pregnancy, cervical Bishop score, perinatal outcome, induced labor process, induced labor outcome and incidence of adverse events were observed. This study obtained the informed consent of the subjects and signed the informed consent of clinical research. The result is 1: 1. There was no significant difference between the study group and the control group in the basic data of age (age), pregnancy time (secondary age, birth age (week) and pregnant women's body mass index (BMI) (P 0.05), and there was no significant difference between the two groups (P 0.05, P < 0.05), and there was no significant difference between the two groups (P > 0.05), and there was no significant difference between the two groups. There was no significant difference in the number of gestational diabetes mellitus and hypertensive disorder complicating pregnancy between the study group and the control group (P 0.05). The difference between the two groups in the number of oligohydramnios was significant (P 0.05), which was statistically significant. There was no significant difference in cervical maturation between the study group and the control group before treatment (P 0.05). After treatment, there was significant difference in promoting cervical maturation between the study group and the control group (P 0.05), and the time of balloon action in the study group was significantly shorter than that in the control group (P 0.05). The effective rate of cervical maturation in the study group was significantly higher than that in the control group (P 0.05). The balloon abscission rate in the study group was significantly higher than that in the control group (P 0.05), with statistical significance. 4. There was no significant difference in the perinatal outcomes between the study group and the control group in terms of birth weight, body length, neonatal asphyxia and fetal distress (P 0.05, P 0.05, P < 0.05). There was no significant difference between the study group and the control group in infection and other complications, there was no significant difference in postpartum hemorrhage, umbilical cord prolapse complications, there was significant difference between the two groups. There was no significant difference in the success rate of induced labor and the rate of cesarean section between the study group and the control group (P 0.05), and there was significant difference between the study group and the control group in the time of labor, the first stage of labor and the stage of labor latency (P 0.05). There was no significant difference between the active stage and the second stage of labor (P 0.05), and there was no statistical significance. There was no significant difference in total cases of cesarean section between the study group and the control group (P 0.05). Because of social factors, the number of cases of umbilical cord prolapse converted to cesarean section in the study group was significantly higher than that in the control group (P 0.05). In the study group, the number of patients undergoing cesarean section due to abnormal labor was significantly lower than that of the control group (P 0.05). There was no significant difference in the number of caesarean section cases between the study group and the control group (P 0.05). Conclusion: the single and double chamber balloon of the same volume has its advantages and disadvantages in the induction of labor during term pregnancy. The clinical work should be analyzed in order to improve the quality of obstetrics and reduce the occurrence of adverse events.
【學(xué)位授予單位】：蘇州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R719.3

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王金鳳;王俊霞;;不同劑量米索前列醇陰道給藥對(duì)宮頸擴(kuò)張的觀察[J];臨床心身疾病雜志;2007年03期

2 安巖;;早期妊娠三種促進(jìn)宮頸擴(kuò)張方法的臨床比較[J];中國(guó)實(shí)用醫(yī)藥;2010年31期

3 胡友文;段麗君;祝幼榮;;安定促進(jìn)宮頸擴(kuò)張65例臨床分析[J];臨床醫(yī)學(xué);1985年06期

4 高耀潔,張世平,侯家欣,馬潔,郭競(jìng)先;中藥牛膝擴(kuò)張宮頸附128例報(bào)告[J];新醫(yī)學(xué);1987年05期

5 胡泳梅;陳希鋃;滿守環(huán);;新型宮頸擴(kuò)張塞的臨床應(yīng)用[J];江西醫(yī)藥;1991年06期

6 劉寶華;莊留琪;;宮頸擴(kuò)張塞的應(yīng)用[J];國(guó)外醫(yī)學(xué)(計(jì)劃生育分冊(cè));1992年04期

7 王瑞雪;46例宮頸擴(kuò)張困難的處理方法[J];青島醫(yī)藥衛(wèi)生;1996年04期

8 閆素文,鄭玲,王夢(mèng)醒;宮頸擴(kuò)張鎮(zhèn)痛棒的臨床應(yīng)用[J];現(xiàn)代手術(shù)學(xué)雜志;1997年04期

9 劉慧霞;;宮頸癌合并妊娠1例并文獻(xiàn)復(fù)習(xí)[J];中國(guó)醫(yī)藥指南;2014年05期

10 王靜云;;不同軟化宮頸藥物在絕經(jīng)后婦女取IUD術(shù)中的效果分析[J];實(shí)用婦產(chǎn)科雜志;2008年05期

相關(guān)會(huì)議論文 前4條

1 商壽玲;李奕;張鈺娟;張鈺;;負(fù)壓吸引術(shù)中擴(kuò)張宮頸及鎮(zhèn)痛方法的比較性研究[A];中華醫(yī)學(xué)會(huì)第五屆全國(guó)計(jì)劃生育學(xué)術(shù)會(huì)議資料匯編[C];2004年

2 Anitn Sik Y au KAN;Ernest Hung Y u NG;Pak Chung Ho;;在負(fù)壓吸引終止早期妊娠中兩種宮頸周圍阻滯緩解疼痛技術(shù)的作用和比較[A];澳門、香港、內(nèi)地生殖健康研討會(huì)論文集[C];2004年

3 周麗紅;陳丹;毛雪梅;金卓杏;;米索前列醇用于宮腔鏡手術(shù)前宮頸擴(kuò)張的臨床觀察[A];第四屆長(zhǎng)三角婦產(chǎn)科學(xué)術(shù)論壇暨浙江省2009年婦產(chǎn)科學(xué)術(shù)年會(huì)論文匯編[C];2009年

4 金力;范光升;李艷;;米索前列醇對(duì)早期妊娠負(fù)壓吸宮術(shù)中軟化宮頸的作用[A];第八次全國(guó)婦產(chǎn)科學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2004年

相關(guān)重要報(bào)紙文章 前1條

1 北京中醫(yī)藥大學(xué)教授 李忠 博士;守護(hù)宮頸健康做幸福女人[N];衛(wèi)生與生活報(bào);2006年

相關(guān)碩士學(xué)位論文 前3條

1 王玉妹;相同容量的宮頸擴(kuò)張單腔球囊與COOK宮頸擴(kuò)張雙腔球囊在足月妊娠引產(chǎn)中的臨床療效比較[D];蘇州大學(xué);2016年

2 王路陽(yáng);不同宮頸擴(kuò)張張力誘導(dǎo)大鼠脊髓cFos及代謝性谷氨酸受體5的表達(dá)變化[D];浙江大學(xué);2014年

3 焦翠翠;TRPV1在急性宮頸擴(kuò)張所致的內(nèi)臟痛中的作用與機(jī)制[D];浙江大學(xué);2015年

，

本文編號(hào)：2040036